Barclays PLC Acquires 1,104 Shares of Transcat, Inc. (NASDAQ:TRNS)

Barclays PLC grew its position in shares of Transcat, Inc. (NASDAQ:TRNS) by 7.3% in the 4th quarter, Holdings Channel reports. The firm owned 16,234 shares of the scientific and technical instruments company’s stock after acquiring an additional 1,104 shares during the quarter. Barclays PLC’s holdings in Transcat were worth $1,717,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bessemer Group Inc. increased its stake in Transcat by 1,692.4% in the fourth quarter. Bessemer Group Inc. now owns 109,608 shares of the scientific and technical instruments company’s stock valued at $11,590,000 after purchasing an additional 103,493 shares in the last quarter. ACK Asset Management LLC bought a new position in shares of Transcat during the fourth quarter valued at about $4,758,000. Raymond James Financial Inc. purchased a new position in shares of Transcat in the 4th quarter worth approximately $2,071,000. JPMorgan Chase & Co. grew its stake in Transcat by 153.1% in the 4th quarter. JPMorgan Chase & Co. now owns 26,434 shares of the scientific and technical instruments company’s stock valued at $2,795,000 after purchasing an additional 15,991 shares during the period. Finally, Neuberger Berman Group LLC raised its position in Transcat by 1.8% in the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock worth $92,415,000 after acquiring an additional 15,723 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on TRNS. Northland Securities reiterated a “market perform” rating and set a $85.00 price target (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. HC Wainwright decreased their price target on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Finally, StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $111.50.

Transcat Trading Up 0.2 %

NASDAQ:TRNS opened at $79.82 on Friday. The company has a fifty day moving average of $76.88 and a 200 day moving average of $93.04. Transcat, Inc. has a 52 week low of $67.56 and a 52 week high of $147.12. The firm has a market capitalization of $743.04 million, a P/E ratio of 43.15 and a beta of 0.69. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.